ABLIVA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.17 SEK | +3.16% |
|
+2.53% | -30.75% |
| 23/02 | Abliva AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
| 2023 | Abliva AB Reaches Patient Enrollment Goal for Wave 1 of the FALCON Study | CI |
Chart calendar Abliva AB
bb62ccf284cc89aca6b1da305.mEbLH4G8_GHbV8Ev_w8gdYnL91LN6gQgrw8C7O7teHs.zyiGTePyrBm-IIR7sT9YAdb8xSiroUNz4GZkuL-dORHrMqlu1-aVIuoV8Q~95c8a3c4d91827a0cb394fd44d6b0dd8
Upcoming events on Abliva AB
Past events on Abliva AB
| 23/02/2024 | Q4 2023 Earnings Release |
| 17/11/2023 | Q3 2023 Earnings Release |
| 25/10/2023 | BioStock Life Science Fall Summit |
| 18/08/2023 | Q2 2023 Earnings Release |
| 30/05/2023 09:30 am | ABGSC Life Science Summit |
| 23/05/2023 | Q1 2023 Earnings Release |
| 16/03/2023 | BioStock Investor Meeting |
| 24/02/2023 | Q4 2022 Earnings Release |
| 22/11/2022 01:00 pm | Q3 2022 Earnings Release |
| 19/08/2022 | Interim 2022 Earnings Release |
| 01/06/2022 12:30 am | Q1 2022 Earnings Release |
| 20/05/2022 04:30 pm | Annual General Meeting |
| 22/02/2022 | FY 2021 Earnings Release |
| 19/11/2021 | Q3 2021 Earnings Release |
| 19/08/2021 | Interim 2021 Earnings Release |
| 20/05/2021 | Annual General Meeting |
| 20/05/2021 | Q1 2021 Earnings Release |
| 19/02/2021 | FY 2020 Earnings Release |
| 20/11/2020 | Q3 2020 Earnings Release |
| 21/08/2020 | Interim 2020 Earnings Release |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,01 0,00 - | 0,13 0,10 34% | 1,86 3,63 -48.71% | 0,15 0,20 -24.5% | 0,00 | 0,00 |
|
EBITDA Million SEK | Released Forecast Spread | -68,6 -68,6 0.05% | -74,7 -94,0 20.54% | -57,5 -78,6 26.81% | -121 -108 -11.92% | 0,00 | 0,00 |
|
EBIT Million SEK | Released Forecast Spread | -73,4 -69,4 -5.64% | -77,1 -85,6 9.93% | -60,1 -81,0 25.84% | -123 -113 -9.32% | 0,00 | 0,00 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -73,5 -70,8 -3.86% | -77,0 -94,1 18.21% | -60,0 -83,4 28.04% | -123 -113 -9.33% | 0,00 | 0,00 |
|
Net income Million SEK | Released Forecast Spread | -68,4 -68,8 0.57% | -77,0 -89,0 13.52% | -60,0 -83,4 28.04% | -123 -113 -9.34% | -85,3 | -95,5 |
|
EPS SEK | Released Forecast Spread | -0,94 -0,65 -44.34% | -0,45 -0,65 30.77% | -0,24 -0,35 31.43% | -0,33 -0,32 -3.13% | -0,12 | -0,09 |
| Announcement Date | 28/02/19 | 19/02/20 | 19/02/21 | 29/04/22 | 24/02/23 | 23/02/24 |
Quarterly results
| Fiscal Period | December | 2021 Q3 |
|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,09 0,00 - |
|
EBITDA Million SEK | Released Forecast Spread | -34,2 -20,0 -70.94% |
|
EBIT Million SEK | Released Forecast Spread | -34,9 -21,0 -65.96% |
| Announcement Date | 19/11/21 |
| Today 01:35 am | EXELIXIS, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release |
| 01/05/2024 | MACROGENICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | REGENXBIO INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 04:30 pm | NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 02/05/2024 01:35 am | SAREPTA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | GERON CORPORATION: Q1 2024 Earnings Release |
Past sector events for Abliva AB
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ABLI Stock
- Calendar Abliva AB
